PRKCB and B-cell chronic lymphocytic leukemia: Accordingly, the Eμ-TCL1 mouse model is widely accepted as a model of aggressive CLL and has been extensively used to study the role of mouse orthologs of various genetic players in CLL such as BTK, PRKCB, and TP53 [6, 9–11].